T/SDHCIA 031-2022 Active Group standards

T/SDHCIA 031-2022 Cefalosporin medicinal intermediate by-product 2-mercaptobenzothiozole (MBT)

T/SDHCIA 031-2022 Cefalosporin medicinal intermediate by-product 2-mercaptobenzothiozole (MBT)

Publish Date: 2022-10-27 Implement Date: 2022-10-27 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us
Price: $ 20.00
Out of stock

Basic Information

Standard Code: T/SDHCIA 031-2022
Standard Type: Group standards
Standard Status: Active
is_force_gb: no
CCS Name: -
ICS Name: Surfactants and other auxiliary agents
Publish Date: 2022-10-27
Implement Date: 2022-10-27

Scope

Main technical content: This document specifies the requirements, test methods, inspection rules, marking, packaging, transportation, and storage of 2-mercaptobenzothiazole (MBT), a by-product of cephalosporin pharmaceutical intermediates. This document is applicable to the production process of cephalosporin drugs, such as the production of cefazolin, during which 2-mercaptobenzothiazole (MBT) is produced as a by-product. In the production process, an active ester containing the S-(2-benzothiazole) structure is acylated, separated, and refined to obtain the final product.

Development Information

Related Standards

Contact Us